INTEGRAL
24 Dec 25
Integrated Next-Generation Tools for Early Infection Control and Antibiotic Resistance Reduction in Poultry Abstract: The INTEGRAL project aims to transform
Integrated Next-Generation Tools for Early Infection Control and Antibiotic Resistance Reduction in Poultry Abstract: The INTEGRAL project aims to transform
Innovative and sustainable strategies for the control of grapevine moth and mealybug in vineyards Abstract: The PHEROVID proposal aims to
Monitoring of Urinary Biomarkers in Bathrooms for the Non-Invasive Evaluation of Athlete Health and Performance Abstract: The OLYMPIA project aims
Recently, the Leitat Terrassa facilities hosted the consortium meeting of the GUTBABI project, a PCPP 2023, where project partners gathered
Dual Compact Reformer for Hydrogen Generation Abstract: The ROAD2H2 project aims to facilitate the adoption of hydrogen as an energy
Modification of silica with bio-based compounds for its use as a reinforcing filler in tires The BIOBASADOS-MS project aims to
Safe by design (bi)functional technical textiles Abstract: The FUNTEX project aims to develop a new generation of safer functional textiles
The iDIABETES project has developed two non-invasive devices to measure glucose in sweat and saliva. The one designed by Leitat,
On October 10, the EGFR-LYTAC project consortium met in person at the facilities of the Center for Genomic Regulation (CRG),
Leitat consolidates its position as one of Spain’s leading technological centres in research, development and innovation, after obtaining approval for
A follow-up meeting of the MINERALS project was recently held at ACCIONA’s facilities, in Madrid, one of the partners of
Leitat has been recognised with the Innovation Capacity Award from the Vilanova del Camí City Council, granted within the framework
The partners of the LiquiDx project gathered on 18 September 2025 at the Biobanco del Sistema Sanitario Público de Andalucía
At Leitat, we held a new follow-up meeting for the NIMBI project together with our project partner, ACCIONA, at our
Cancer immunotherapy, also known as immuno-oncology, represents one of the greatest revolutions in cancer treatment in recent decades. This therapeutic
DHA (docosahexaenoic acid) is a molecule generally used for its antioxidant activity, but it is very unstable. The GiGa-3 project
Phone. (+34) 937 882 300
